Skip to main content
Livermore
Livermore
ZHEN

Quadrant Capital Group LLC

SEC CIK
0001650717
Latest filing
Aug 14, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of RARE by Quadrant Capital Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−400−100.0%Sold outHolders
Q4 2025400$9.20K<0.1%+264+194.1%AddedHolders
Q3 2025136$4.09K<0.1%+136NewHolders
Q2 20250$00.0%−298−100.0%Sold outHolders
Q1 2025298$10.8K<0.1%+11+3.8%AddedHolders
Q4 2024287$12.1K<0.1%00.0%UnchangedHolders
Q3 2024287$15.9K<0.1%00.0%UnchangedHolders
Q2 2024287$11.8K<0.1%−110−27.7%ReducedHolders
Q1 2024397$18.5K<0.1%+80+25.2%AddedHolders
Q4 2023317$15.2K<0.1%−94−22.9%ReducedHolders
Q3 2023411$14.7K<0.1%−756−64.8%ReducedHolders
Q2 20231,167$53.8K<0.1%−163−12.3%ReducedHolders
Q1 20231,330$53.3K<0.1%+406+43.9%AddedHolders
Q4 2022924$42.8K<0.1%+487+111.4%AddedHolders
Q3 2022437$18.0K<0.1%+266+155.6%AddedHolders
Q2 2022171$10.0K<0.1%+149+677.3%AddedHolders
Q1 202222$1.00K<0.1%−37−62.7%ReducedHolders
Q4 202159$5.00K<0.1%+34+136.0%AddedHolders
Q3 202125$2.00K<0.1%+22+733.3%AddedHolders
Q2 20213$00.0%−54−94.7%ReducedHolders
Q1 202157$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.